| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.415 | 21.618 | 24.107 | 26.889 | 27.271 | 27.473 | 29.694 | 29.470 | 30.425 | 29.901 |
| Total Income - EUR | 21.415 | 21.624 | 24.107 | 26.889 | 27.271 | 27.706 | 29.766 | 29.490 | 37.975 | 30.098 |
| Total Expenses - EUR | 18.416 | 17.454 | 19.313 | 19.732 | 22.872 | 24.690 | 20.439 | 20.691 | 18.999 | 28.155 |
| Gross Profit/Loss - EUR | 2.999 | 4.170 | 4.794 | 7.157 | 4.400 | 3.016 | 9.326 | 8.799 | 18.976 | 1.943 |
| Net Profit/Loss - EUR | 2.357 | 3.521 | 3.293 | 6.350 | 3.582 | 2.244 | 8.496 | 8.030 | 15.996 | 1.364 |
| Employees | 4 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ro-Ge-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 28.561 | 26.718 | 43.318 | 32.725 | 25.710 | 14.734 | 6.704 | 2.986 | 4.775 | 51.876 |
| Current Assets | 6.636 | 30.857 | 9.501 | 13.952 | 22.138 | 33.235 | 48.114 | 60.262 | 73.347 | 27.824 |
| Inventories | 0 | 0 | 0 | 204 | 252 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.478 | 1.501 | 3.055 | 2.314 | 3.319 | 3.508 | 980 | 39 | 3 | 305 |
| Cash | 5.158 | 29.356 | 6.446 | 11.434 | 18.567 | 29.727 | 47.134 | 60.223 | 73.344 | 27.518 |
| Shareholders Funds | 31.239 | 34.442 | 37.153 | 42.821 | 45.573 | 46.954 | 54.408 | 62.607 | 78.413 | 79.339 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.622 | 23.392 | 15.666 | 3.857 | 2.275 | 1.016 | 410 | 642 | 839 | 555 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ro-Ge-Med S.r.l.